,ID,Reference,Source Clone name,Sequence,Motif,Target-tumor,Target-cell,Receptors-biomarker,Phage/Library,In vitro/Ex-vivo,In vivo,Homing/targeting,Payloads,patent
0,1116,Jiang YQ et al. Mol Med. 2006 Apr-Jun;12(4-6):81-7.,HCC79,KSLSRHDHIHHH,,Hepatocellular carcinoma,Tumor cell,Her-2 and ErbB-2,M13/ 12-mer peptide library,"Human hepatoma cell line SMMC-7721, BEL-7402, and HL-02",BABL/c mice,Homing,Toxic shock syndrome toxin 1 (TSST-1),US 2009/0274625 A1
1,1360,Lo A et al. Mol Cancer Ther. 2008 Mar;7(3):579-89.,Novel peptide (SP94),SFSIIHTPILPL,P-I/L-L-P,Hepatocellular carcinoma,,,M15 phage/12 mer peptide library,"59T human hepatocellular carcinoma lines, Changliver, human hepatocellular carcinoma lines, HA22T, human hepatocellular carcinoma lines, HA22T, human hepatocellular carcinoma lines, Hep3B, human hepatocellular carcinoma lines HepG2 human hepatocellular carcinoma lines, J5, human hepatocellular carci",SCID mice bearing human hepatocellular carcinoma xenografts,Homing,SP94 and liposomal doxorubicin,US 2009/0136418A1
2,1754,Zhu Z et al .Biomaterials 2011 Dec;32(35):9525-35.,iRGD peptide,CRGDRCPDC,RGD,Hepatocellular carcinoma,,Neuropilin-1,,H22 cells,"ICR mice (6Ã¢â¬â7 weeks, 23Ã¢â¬â25ÃÂ g)",Homing,Nanoparticles,
